Trump healthcare policy – The Milli Chronicle

Sunday, December 21, 2025

Latest:

Trump and Leading Drugmakers Reach Landmark Agreement to Lower Medicine Prices
Nvidia and Intel Investment Gains Regulatory Approval, Boosting US Chip Ambitions
Saudi Arabia and GCC Leadership Reinforce Regional Unity in High-Level Riyadh Meeting
AlUla Revives Tantora Ceremony, Celebrating Living Heritage and Seasonal Wisdom
Saudi Transport Authority Strengthens Road Safety Through Nationwide Enforcement Drive

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle December 21, 2025December 21, 2025 affordable medicines America, drug price transparency, drugmaker government deal, healthcare cost reduction, lower prescription costs, Medicaid drug pricing, Medicaid medicine savings, medicine price reform, most favored nation pricing, patient access medicines, pharma industry collaboration, pharmaceutical investment USA, pharmaceutical pricing agreement, prescription drug affordability, prescription savings plan, Trump healthcare policy, TrumpRx platform, US drug policy update, US drug price cuts, US healthcare reform

Trump and Leading Drugmakers Reach Landmark Agreement to Lower Medicine Prices

New partnership promises affordability, innovation, and broader access to essential medicines. The United States has taken a major step toward

Featured News World

NewsDesk Milli Chronicle October 1, 2025October 1, 2025 healthcare policy news, international drug pricing standards, Medicaid drug price cuts, Pfizer CEO Albert Bourla, Pfizer drug prices, Pfizer global pricing, Pfizer lowers drug prices, Pfizer pharmaceutical news, Pfizer shares surge, Pfizer White House agreement, pharmaceutical industry reforms, prescription drug price reform, Trump administration healthcare deal, Trump administration pharma deal, Trump healthcare policy, TrumpRx platform, U.S. drug pricing reform, U.S. healthcare affordability, U.S. prescription drug costs, White House healthcare initiative

Pfizer Strikes Landmark Deal With Trump Administration to Lower Drug Prices

In a move hailed as a turning point for U.S. healthcare, Pfizer agrees to align drug prices with global standards